Fulfillment of the following three conditions confirms a diagnosis of aldosteronism: (1) autonomous excess aldosterone production evidenced with an ARR > 35; (2) a TAIPAI score larger than 60% [7] ; (3) postsaline loading PAC > 10 ng/dl, or PAC/PRA> 35 (ng/dL)/ (ng/mL/h) shown in a post capotopril/ losartan test, or PAC>6 ng/dL indicated by a fludrocortisone suppression test [6] . (Abbreviations: PAC, plasma aldosterone concentration; PRA, plasma renin activity)
The standard protocol to identify aldosteronism
The diagnosis of aldosteronism was established in hypertensive patients on the basis of the following criteria [3] [4] [5] [6] :(Supplementary Figure 1) 
Confirmation
Fulfillment of the following three conditions confirms a diagnosis of aldosteronism: (1) autonomous excess aldosterone production evidenced with an ARR > 35; (2) a TAIPAI score larger than 60% [7] ; (3) postsaline loading PAC > 10 ng/dl, or PAC/PRA> 35 (ng/dL)/ (ng/mL/h) shown in a post capotopril/ losartan test, or PAC>6 ng/dL indicated by a fludrocortisone suppression test [6] . (Abbreviations: PAC, plasma aldosterone concentration; PRA, plasma renin activity)
Lateralization
APA is identified on the basis on the following four conditions: (1) autonomous excess aldosterone production evidenced with an ARR > 35, a TAIPAI score larger than 60% [7] , and post-saline loading PAC > 10 ng/dl; (2) adenoma evidenced with a CT scan for pre-operative evaluation [6] ; (3) lateralization of aldosterone secretion at AVS or during dexamethasone suppression NP-59 SPECT/ CT [8] ; (4) pathologically proven adenoma after an adrenalectomy for those with operations, and subsequent emergence of either a cure pattern of hypertension without anti-hypertensive agents or improvement in hypertension, potassium, PAC, and PRA [5, 6, 9] . Idiopathic hyperaldosteronism (IHA) is distinguished on the basis on the following four criteria: (1) autonomous excess aldosterone production evidenced with an ARR > 35, a TAIPAI score larger than 60% [7] , and post-saline loading PAC > 10 ng/dl (2) evidence of bilateral diffuse enlargement indicated by a CT scan for pre-operative evaluation; (3) non-lateralization of aldosterone secretion at AVS or during dexamethasone suppression NP-59 SPECT/CT [8] ; (4) evidence of diffuse cell hyperplasia reported in following pathology studies for those with operations.
